Cal 25 and neuron-specific enolase (NSE) as tumour markers for intramabdominal desmoplastic small round-cell tumours
1997

Cal 25 and NSE as Tumor Markers for Desmoplastic Small Round-Cell Tumors

Sample size: 7 publication Evidence: low

Author Information

Author(s): K Fizazi, F Farhat, C Theodore, O Rixe, A Le Cesne, E Comoy, T Le Chevalier

Primary Institution: Institut Gustave-Roussy

Hypothesis

Are Cal 25 and neuron-specific enolase (NSE) effective tumor markers for monitoring intra-abdominal desmoplastic small round-cell tumors?

Conclusion

Cal 25 and NSE are frequently elevated in patients with intra-abdominal desmoplastic small round-cell tumors but are not reliable for monitoring disease progression.

Supporting Evidence

  • Cal 25 was initially high in six of the seven patients (86%) with a median value of 200 U ml-1.
  • NSE was elevated before therapy in three of the five patients (60%) for whom assay results were available.
  • Cal 25 normalized in five out of six cases during chemotherapy.
  • NSE always normalized during chemotherapy.
  • At progression, Cal 25 was elevated in two out of four cases several weeks before clinical relapse.

Takeaway

Doctors looked at two blood tests, Cal 25 and NSE, to see if they could help track a rare type of cancer in kids and young adults. They found that while these tests often showed high levels, they didn't really help in knowing how the cancer was doing.

Methodology

Seven patients were screened for various tumor markers before treatment, and their levels were monitored during chemotherapy.

Limitations

The study involved a small sample size and lacked a control group.

Participant Demographics

Four males and three females, with a mean age of 22 years (range 15-30 years).

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication